Redwire BioFabrication Facility Effectively Prints First Human Knee Meniscus on ISS

Redwire Firm (NYSE: RDW), a pacesetter in space infrastructure for the next period space monetary system, launched as we converse that it has effectively 3D bioprinted the first human knee meniscus on orbit using its upgraded 3D BioFabrication Facility (BFF) on the Worldwide Space Station (ISS). This milestone opens the door to improved treatments for meniscal accidents, one of many frequent accidents for U.S. Service Members.

“It’s a groundbreaking milestone with necessary implications for human effectively being,” acknowledged Redwire Govt Vice President John Vellinger. “Demonstrating the ability to effectively print superior tissue equal to this meniscus is a severe leap forward in the direction of the occasion of a repeatable microgravity manufacturing course of for reliable bioprinting at scale.”

The print returned to Earth onboard the SpaceX Crew-6 Mission for analysis following worthwhile print operations in July. Sooner than returning to Earth, the print was cultured for 14 days on the ISS in Redwire’s Superior Space Experiment Processor (ADSEP). The print was carried out as part of the BFF-Meniscus-2 Investigation with the Uniformed Corporations Faculty of the Nicely being Sciences Coronary heart for Biotechnology (4D Bio3), a biomedical evaluation coronary heart that explores and adapts promising biotechnologies for warfighter revenue. The investigation was carried out by NASA astronauts Frank Rubio, Warren “Woody” Hoburg, and Stephen Bowen, and UAE astronaut Sultan Al Neyadi.

Redwire bioprinting experiment that produced knee meniscus tissue. Credit score rating: Redwire

BFF is part of Redwire’s rising portfolio of utilized sciences and progressive on-orbit capabilities enabling human spaceflight missions and industrial microgravity evaluation and enchancment in low-Earth orbit (LEO). Redwire has developed 20 evaluation facilities for the ISS with 10 at current engaged on station to ship world-leading evaluation. In July, Redwire launched plans to open a 30,000 sq. foot, state-of-the-art microgravity payload enchancment facility with a mission operations coronary heart on the Novaparke Innovation & Know-how Campus in Floyd County, Indiana, as the company appears to increase manufacturing of significant utilized sciences enabling human spaceflight missions and industrial microgravity evaluation and enchancment in LEO.

On the upcoming SpaceX CRS-29 resupply mission to the ISS in November, Redwire may be launching microgravity evaluation payloads centered on pharmaceutical drug enchancment and regenerative medicine, along with an experiment in bioprinting cardiac tissue.

About Redwire

Redwire Firm (NYSE: RDW) is a worldwide chief in mission very important space choices and extreme reliability components for the next period space monetary system, with valuable psychological property for photo voltaic vitality period, in-space 3D printing and manufacturing, avionics, very important components, sensors, digital engineering and space-based biotechnology. It combines a few years of flight heritage with an agile and progressive custom. The company’s “Heritage plus Innovation” approach permits it to combine confirmed effectivity with new, progressive capabilities to supply its shoppers with the establishing blocks for the present and manner ahead for space infrastructure. For additional information, please go to redwirespace.com.